COVID-19 and Childhood Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

100,000

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

COVID-19Childhood CancerChildhood Leukemia, Acute Lymphoblastic

Trial Locations (1)

Karolinska Institutet, Stockholm

All Listed Sponsors

collaborator

The Swedish Research Council

OTHER_GOV

collaborator

The Swedish Childhood Cancer Fund

UNKNOWN

lead

Karolinska Institutet

OTHER